Regencell Bioscience Ltd (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti
Bozor to'siqlarining yo'qligi va erta bosqichdagi sinovlar xavflarni keltirib chiqaradi, biroq Regencell Bioscience (RGC) ADHD va autizm uchun tabiiy vositalarni sotish orqali foyda o'sishini kuzatadi. Kompaniyaning o'rtacha P/E ko'rsatkichi baholashning qoplash dinamikasini aks ettiradi, bunda joriy daraja -237.80 ni tashkil etadi. Strategiya neyrorivojlanish buzilishlariga chazilgan bemorlar uchun sintetik dori vositalariga ekologik toza muqobil sifatida an'anaviy Xitoy tibbiyotini joriy etishga asoslangan.
Regencell (RGC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi ko'rsatkichlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Regencell Bioscience|RGC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Regencell Corp|RGC - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited|RGC - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Regencell Bioscience|Oraliq qoplash koeffitsiyenti regencellbioscience.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
RGC - Sof foyda|Kutilayotgan foyda Regencell Bioscience|RGC - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Regencell Bioscience Ltd|RGC - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Regencell Bioscience Holdings Limited|RGC - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Regencell Bioscience|RGC - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi regencellbioscience.com|RGC - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Regencell Bioscience
Kompaniyaning har tomonlama tahlili:regencellbioscience.com
P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini aks ettiradi, bu esa investorga kotirovkalarni biznesning haqiqiy daromadlari bilan solishtirish orqali aktiv uchun haddan tashqari to'lov darajasini aniqlash imkonini beradi. Regencell Bioscience (RGC) kompaniyasining P/E koeffitsiyentini tahlil qilishda, nevrologik kasalliklarni davolovchi dori vositalarining tijoratlashtirish salohiyatini hisobga olish lozim, chunki Osiyo sug'urta fondlaridan kelajakdagi to'lovlar biznesning joriy fundamental qiymatini oqlashi mumkin.
Raqobatdosh kompaniyalar tahlili
Kapitalizatsiyaning foydaga nisbati biogen.com BIIB|P/E multiplikatori NBIX|Axsome (AXSM) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori ACAD (ACADIA Pharmaceuticals Inc)|Xenon Corp (XENE) - Kapitalizatsiyaning foydaga nisbati|VKTX - Narxning foydaga nisbati|SUPN (supernus.com) - Narx-foyda multiplikatori|CPRX: P/E multiplikatori|Narx-foyda koeffitsiyenti Denali|HRMY (Harmony Pharma) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Biohaven Corp BHVN|Narxning foydaga nisbati Amylyx Pharmaceuticals (AMLX)|Narxning foydaga nisbati TRVI (trevitherapeutics.com)|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex - Narxning foydaga nisbati|CBLL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRTA (Prothena Corporation)|ALEC: P/E multiplikatori|ANNX (annexonbio.com) - Narxning foydaga nisbati|OMER (Omeros Corp) - P/E multiplikatori|Neurogene Inc (NGNE) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati AC Immune Corp (ACIU)|VYGR - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Neumora Therapeutics NMRA|Biznesning o‘zini qoplash muddati scilexholding.com (SCLX)|Tevogen Bio - P/E multiplikatori|Alpha Cognition (ACOG) - Narx-foyda koeffitsiyenti|CGTX: P/E multiplikatori|IKT - Biznesning o‘zini qoplash muddati|SAVA (Cassava Sciences, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Assertio Therapeutics ASRT|Narxning foydaga nisbati Coya Therapeutics, Inc. (COYA)|vistagen.com - Narx-foyda multiplikatori|P/E multiplikatori OVID (Ovid Therapeutics)|ABOS - Narx-foyda koeffitsiyenti|CervoMed Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alterity Therapeutics|clene.com (CLNN) - Narxning foydaga nisbati|PepGen - Kompaniya qiymatining sof foydaga nisbati|JUNS (Jupiter Neurosciences) - P/E multiplikatori|RLMD - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti gracetx.com GRCE|Narxning foydaga nisbati Firefly Neuroscience AIFF|KLTO: Narx-foyda multiplikatori|NeuroSense Therapeutics, Ltd. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Reviva Pharmaceuticals, Inc.|MTVA (metaviatx.com) - Narx-foyda koeffitsiyenti|neuraxis.com (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical Technologies, Inc.|PASG: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Athira Pharma, Inc. ATHA|Kompaniya qiymatining sof foydaga nisbati ADXN|Alzamend - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Cyclerion Therapeutics|PTIX: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Pasithea Therapeutics Corp. KTTA|CRGT (Cortigent Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati avenuetx.com ATXI|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|Cara Therapeutics Inc. - Narx-foyda multiplikatori|P/E multiplikatori CHRO (Chromocell Therapeutics Corporation)|ELYM - Narx-foyda koeffitsiyenti|Intra-Cellular - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGN (NKGen Biotech Inc) - Narxning foydaga nisbati|Narxning foydaga nisbati NeuroBo|Narxning foydaga nisbati SAGE|Narx-foyda koeffitsiyenti SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|anewmeds.com - Narxning foydaga nisbati|Cerevel - P/E multiplikatori
